| Mark S Flora, MD | |
|
1600 Prairie Center Pkwy, Brighton, CO 80601-4006 | |
| (303) 458-1600 | |
| Not Available |
| Full Name | Mark S Flora |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 45 Years |
| Location | 1600 Prairie Center Pkwy, Brighton, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417929019 | NPI | - | NPPES |
| 930095372 | Other | CO | RR MEDICARE |
| 01257799 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 25779 (Colorado) | Secondary |
| 207Q00000X | Family Medicine | 31039 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Weisbrod Memorial County Hospital | Eads, CO | Hospital |
| Platte Valley Medical Center | Brighton, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Platte Valley Medical Group Llc | 5890054100 | 75 |
| County Of Kiowa Hospital District | 5698716827 | 8 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
| Entity Name | Yuma District Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841343407 PECOS PAC ID: 6305758830 Enrollment ID: O20031223000344 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
| Entity Name | County Of Kiowa Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700115938 PECOS PAC ID: 5698716827 Enrollment ID: O20090520000596 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
| Entity Name | Yuma District Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1336263417 PECOS PAC ID: 6305758830 Enrollment ID: O20091210000324 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
| Entity Name | Brighton Community Emergency Physicians, Lpa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639454242 PECOS PAC ID: 0244405488 Enrollment ID: O20111216000019 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
| Entity Name | Scl Health Medical Group - Denver Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083021083 PECOS PAC ID: 0840513552 Enrollment ID: O20150106000131 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
| Entity Name | Healogics Specialty Physicians Of Colorado-professional Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114331006 PECOS PAC ID: 4183941834 Enrollment ID: O20150318000983 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
| Entity Name | Platte Valley Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275283574 PECOS PAC ID: 5890054100 Enrollment ID: O20180112000840 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark S Flora, MD 11442 Quivas Way, Westminster, CO 80234-2621 Ph: (720) 261-3823 | Mark S Flora, MD 1600 Prairie Center Pkwy, Brighton, CO 80601-4006 Ph: (303) 458-1600 |
News Archive
AIDS Healthcare Foundation (AHF) today lauded a recent San Francisco study which documented a significant increase in HIV testing rates among high-risk groups who have not had to undergo written consent for the procedure, a study finding which supports a change in testing protocol that the Centers for Disease Control (CDC) first recommended in its revised 2006 guidelines for HIV testing, but a change that has not been widely adopted nationwide.
The Food and Drug Administration (FDA) in the USA has concluded that Carbaglu (carglumic acid) for treatment of N-acetylglutamate synthase (NAGS) deficiency meets the criteria for fast track designation.
New research shows further evidence between COVID-19 infection and the development of long-term neurological symptoms. The findings found COVID-induced neuroinflammation and microvascular injury contributed to dementia-like symptoms. However, they also found evidence indicating a low possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly invading the brain.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Scientists have identified DNA changes that can cut a person's lifespan by up to three years.
› Verified 6 days ago
John Fontenot, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1860 E Egbert St, Brighton, CO 80601 Phone: 303-659-4000 Fax: 303-659-9306 | |
Kristine Lynn Ray, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1606 Prairie Center Pkwy, 300, Brighton, CO 80601 Phone: 734-232-6776 | |
Dr. Stefano H Lee, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1860 E Egbert St, Brighton, CO 80601 Phone: 303-659-4000 Fax: 303-659-9306 | |
Justin Christopher Gabor, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1606 Prairie Center Pkwy Ste 240, Brighton, CO 80601 Phone: 303-659-1152 Fax: 720-685-0027 | |
Dr. Juanita R Redfield, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 859 S 4th Ave, Brighton, CO 80601 Phone: 303-338-4545 | |
Dr. Sonya J Norman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1606 Prairie Center Pkwy Ste 240, Brighton, CO 80601 Phone: 303-659-1152 Fax: 720-685-0027 | |
Dr. Blanca Richmond-coca, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1606 Prairie Center Pkwy, Suite 240, Brighton, CO 80601 Phone: 303-659-1152 Fax: 720-685-0027 |